Biolaw and antimicrobial resistance in Costa Rica

Authors

DOI:

https://doi.org/10.51481/amc.v64i3.1246

Keywords:

Drug resistance microbial, legislation & jurisprudence, health, human rights, legislation, veterinary

Abstract

Antimicrobial resistance represents a danger to human health since it jeopardizes the clinical value of these drugs for the treatment and prevention of infectious diseases. This multisectoral phenomenon requires immediate action, which is why the World Health Organization has urged member countries to adopt action plans against antimicrobial resistance, however, it is necessary to implement a binding legal framework for the regulation of the use of antimicrobials, especially in the sectors with the highest consumption. The formulation of legislation that ensures the prudent use of these drugs in the animal production industry is possible from biolaw. In this way, this article seeks to propose regulations for the optimization of antimicrobials in the livestock sector based on international law. The effectiveness of antimicrobials was found to be an intrinsic common good in the right to human health. The protection of this right, as well as different international declarations, support the regulation
of antimicrobials. In the livestock sector, it is urgent to implement binding measures to reduce the use, especially of those categorized as critically important for human health.

Downloads

Download data is not yet available.

References

Dadgostar P. Antimicrobial resistance: Implications and costs. Infect Drug Resist [Internet]. 2019;12:3903-10. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.2147/IDR.S234610

Rodríguez-Rojas A, Rodríguez-Beltrán J, Couce A, Blázquez J. Antibiotics and antibiotic resistance: a bitter fight against evolution. Int J Med Microbiol. [Internet]. 2013 Ago;303(6-7):293-297. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1016/j.ijmm.2013.02.004.

Organización Mundial de la Salud. Plan de acción mundial sobre la resistencia a los antimicrobianos. [Internet]. Ginebra: OMS; 2016. Recuperado: 18 febrero 2022. En: https://www.who.int/publications/i/item/9789241509763.

Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nat Microbiol. [Internet]. 2019 Ago;4(9):1432-1442. Recuperado: 18 febrero 2022.En: http://dx.doi.org/10.1038/s41564-019-0503-9.

Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet [Internet]. 2016;387(10014):176-87. Disponible en: http://dx.doi.org/10.1016/S0140-6736(15)00473-0

Hwang AY, Gums JG. The emergence and evolution of antimicrobial resistance: Impact on a global scale. Bioorg Med Chem. [Internet]. 2016 Dic;24(24):6440-6445. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1016/j.bmc.2016.04.027.

Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond B Biol Sci. [Internet]. 2015 Jun 05;370(1670):20140082. Recuperado: 18 febrero 2022. Disponible e: http://dx.doi.org/10.1098/rstb.2014.0082.

Behdinan A, Hoffman SJ, Pearcey M. Some global policies for antibiotic resistance depend on legally binding and enforceable commitments. J Law Med Ethics . [Internet]. 2015 Ene 01;43 Suppl 3(S3):68-73. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1111/jlme.12277.

Valdés E. Bioderecho. Epistemologías y aplicaciones en tiempos de pandemia y riesgo existencial. Valencia: Tirant lo Blanch; 2021.

Harring N, Krockow EM. The social dilemmas of climate change and antibiotic resistance: an analytic comparison and discussion of policy implications. Humanit Soc Sci Commun. [Internet]. 2021 May 21;8(1):1-9. Recuperado: 18 febrero 2022. En: https://www.nature.com/articles/s41599-021-00800-2.

Hollis A, Maybarduk P. Antibiotic resistance is a tragedy of the commons that necessitates global cooperation. J Law Med Ethics. [Internet]. 2015;43(S3):33-37. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1111/jlme.12272.

Pahlman K, Fehross A, Fox GJ, Silva DS. Ethical health security in the age of antimicrobial resistance. BMJ Glob Health. [Internet]. 2022 Ene 07;7(1):e007407. Recuperado: 19 febrero 2022. En: http://dx.doi.org/10.1136/bmjgh-2021-007407.

Padiyara P, Inoue H, Sprenger M. Global governance mechanisms to address antimicrobial resistance. Infect Dis (Auckl). [Internet]. 2018 Abr 11;11:1178633718767887. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1177/1178633718767887.

Hoffman SJ, Bakshi R, Rogers Van Katwyk S. How law can help solve the collective action problem of antimicrobial resistance. Bioethics. [Internet]. 2019 Jul 03;33(7):798-804. Recuperado: 19 febrero 2022. En: http://dx.doi.org/10.1111/bioe.12597.

Valdés E. Towards a New Conception of Biolaw. En: Lecaros EVJ, editor. Biolaw and Policy in the Twenty-First Century. Cham, Suiza: Springer Nature; [Internet]. 2019. p. 41-58. Recuperado: 19 febrero 2022. En: http://dx.doi.org/10.1007/978-3-030-05903-3.

Daulaire N, Bang A, Tomson G, Kalyango JN, Cars O. Universal access to effective antibiotics is essential for tackling antibiotic resistance. J Law Med Ethics. [Internet]. 2015;43 Suppl 3(S3):17-21. Recuperado: 20 febrero 2022. En: http://dx.doi.org/10.1111/jlme.12269

Romeo Casabona CM. El Bioderecho y la Bioética, un largo camino en común. Rev iberoam bioét. 2017;0(3):1. Recuperado: 20 febrero 2022. En: http://dx.doi.org/10.14422/rib.i03.y2017.009

Chacón Mata A. El concepto de dignidad humana como fundamento axiológico y ético de los derechos humanos. Rev latinoam derechos hum. 2015;26(1). Recuperado: 20 febrero 2022. En: http://dx.doi.org/10.15359/rldh.26-1.2

Colussi IA. Biolaw and ‘the dual-use dilemma': The freedom of scientific research in relationship with ‘traditional' and emerging sciences and technologies. En: Biolaw and Policy in the Twenty-First Century. Cham: Springer International Publishing; 2019. p. 239-55.

Millar M. A capability perspective on antibiotic resistance, inequality, and child development. En: Ethics and Drug Resistance: Collective Responsibility for Global Public Health. Cham: Springer International Publishing; 2020. p. 225-42.

Gobierno de Costa Rica. Plan De Acción Nacional De Lucha Contra La Resistencia A Los Antimicrobianos Costa Rica 2018-2025. 2019. Recuperado: 20 febrero 2022. En: https://www.ministeriodesalud.go.cr/sobre_ministerio/directrices_dm/DAJ_decreto_41385_decl_plan_lucha_antimicrobianos.pdf

Organización Panamericana de la Salud. Legislación sobre antibióticos en América Latina. Washington: Organización Panamericana de la Salud; 2004.

Gobierno de Costa Rica. Oficialización y declaratoria de interés público y nacional el ""Plan de Acción Nacional de Lucha Contra la Resistencia a los Antimicrobianos Costa Rica 2018-2025"". 2019. Recuperado: 18 febrero 2022. En: http://www.pgrweb.go.cr/scij/Busqueda/Normativa/Normas/nrm_texto_completo.aspx?param1=NRTC&nValor1=1&nValor2=87945&nValor3=114686&strTipM=TC

Asamblea General de las Naciones Unidas. Declaración Universal de Derechos Humanos. 1948.

Lecaros JA. Biolaw and Bioethics: Convergences and Divergences. En: Biolaw and Policy in the Twenty-First Century. Cham: Springer International Publishing; 2019. p. 93-118.

UNESCO. Declaración universal sobre bioética y derechos humanos naciones unidas. 2005.

Littmann J, Buyx A, Cars O. Antibiotic resistance: An ethical challenge. Int J Antimicrob Agents. 2015;46(4):359-61. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1016/j.ijantimicag.2015.06.010

Árdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016;387(10015):296-307. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1016/S0140-6736(15)00470-5

Asociación Médica Mundial. Declaración de la AMM sobre la Resistencia antimicrobiana. Wma.net. 2020. Recuperado: 19 febrero 2022. En: https://www.wma.net/es/policies-post/declaracion-de-la-amm-sobre-la-resistencia-a-los-medicamentos-antimicrobianos/

Ruckert A, Fafard P, Hindmarch S, Morris A, Packer C, Patrick D, et al. Governing antimicrobial resistance: a narrative review of global governance mechanisms. J Public Health Policy. 2020;41(4):515-28. Recuperado: 19 febrero 2022. En: http://dx.doi.org/10.1057/s41271-020-00248-9

Maron DF, Smith TJS, Nachman KE. Restrictions on antimicrobial use in food animal production: an international regulatory and economic survey. Global Health. 2013;9(1):48. Recuperado: 20 febrero 2022. En: http://dx.doi.org/10.1186/1744-8603-9-48

Giubilini A, Birkl P, Douglas T, Savulescu J, Maslen H. Taxing meat: Taking responsibility for one's contribution to antibiotic resistance. J Agric Environ Ethics. 2017;30(2):179-98. Recuperado: 18 febrero 2022. En: http://dx.doi.org/10.1007/s10806-017-9660-0

California Department of Food, Agriculture. CDFA - AHFSS - Antimicrobial Use and Stewardship. Cdfa.ca.gov. [citado el 6 de marzo de 2022]. Recuperado: 20 febrero 2022. En: https://www.cdfa.ca.gov/ahfss/AUS/

Reglamento (UE) 2019/6 del Parlamento Europeo y del Consejo de 11 de diciembre de 2018 sobre medicamentos veterinarios y por el que se deroga la Directiva 2001/82/CE. Europa.eu. Recuperado: 20 febrero 2022. En: https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:32019R0006&from=ES

Reglamento (UE) 2019/4 del Parlamento Europeo y del Consejo Europea de 11 de diciembre de 2018 relativo a la fabricación, la comercialización y el uso de piensos medicamentosos, por el que se modifica el Reglamento (CE) n.o 183/2005 del Parlamento Europeo y del Consejo y se deroga la Directiva 90/167/CEE del Consejo. 2018. Recuperado: 20 febrero 2022. En: https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:32019R0004&from=EN

Published

2022-11-01

How to Cite

Biolaw and antimicrobial resistance in Costa Rica. (2022). Acta Médica Costarricense , 64(3), 1-7. https://doi.org/10.51481/amc.v64i3.1246